Pharma Will Embrace Basket And Umbrella Trials, Despite Challenges

FDA Pushing For Innovation In Trial Design

Endpoints_Panel
The panel agreed novel trial design was necessary - but brought new challenges • Source: AMc
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D